Trifluent Pharma, LLC

Trifluent Pharma, LLC specializes in reusable scar-management dressings. These products are designed to assist in tissue healing and minimize scarring, particularly in clinical settings. Their primary focus is on wound care solutions that support the healing process by managing scar formation.

Trifluent Pharma, LLC is based in the United States. The company’s location aligns with U.S. regulatory frameworks, including compliance with the FDA’s Unique Device Identifier (UDI) system for its products.

Yes, Trifluent Pharma, LLC’s devices are included in the FDA’s Unique Device Identifier (UDI) database. This listing ensures traceability and compliance with U.S. medical device regulations, particularly for reusable scar-management dressings like the RevivaSil Gel Pad Kit.

Trifluent Pharma, LLC’s reusable scar-management dressings fall under regulatory categories relevant to wound care devices in the U.S. The classification aligns with the FDA’s UDI system, which categorizes medical devices for tracking, reporting, and compliance purposes. This ensures their products meet the necessary standards for safety and effectiveness in clinical use.